NewGen’s Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million

NewGen Group Limited (Nasdaq: NIVF) announced a Big Four valuation of US$19 million for its planned UAE-based cell sorting and cytometry leasing business, building on a prior US$17.9 million IP valuation. The company appointed industry veteran Nadeem Malik as Senior Strategic Advisor to lead the UAE/GCC expansion, targeting the high-growth IVF market projected to surge from US$270 million in 2024 to US$444 million by 2030. The initiative aims to capture domestic demand and medical tourism from China and India while leveraging synergies with NewGen's Ras Al Khaimah real estate projects.